Innovative Report on Ablation Technologies Market with New Business Developments and Top Key Companies (J&J, Medtronic, Boston Scientific, Abbott, Smith&Nephew, Olympus, BTG) | Forecasts 2021-2025

BusinessIndustryReports has recently broadcasted a new study to its broad research portfolio, which is titled as “Global Ablation Technologies Market” Research Report 2021 provides an in-depth analysis of the Ablation Technologies with the forecast of market size and growth. The analysis includes addressable market, market by volume, market share by business type and by segment (external and in-house). The research study examines the Ablation Technologies on the basis of a number of criteria, such as the product type, application, and its geographical presence.

Global Ablation Technologies Market Overview:

The Global Ablation Technologies Market has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Ablation Technologies market size to maintain the average annual growth rate of 9.07% from $21.5 Billion in 2015 to $27.9 Billion in 2019, market analysts believe that in the next few years, Ablation Technologies market size will be further expanded, we expect that by 2025, The market size of the Ablation Technologies will reach $44.0 Billion.

Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/284208 .

As per the market research study, Ablation refers to minimally invasive procedures that entail the surgical excision of body tissues. Ablation procedures are gaining rapid popularity across the globe since they are used in minimally invasive ablation procedures. Minimally invasive medical procedures gain precedence over invasive procedures because the former includes relatively lower post-procedural risks, shorter recovery time, and hospital stays.

Most important key factors driving the growth of the Global Ablation Technologies Market are growing base of the geriatric population across the globe, lower risk of damage to tissues, lower risk of infection, quick recovery, and cost-effectiveness of ablation.

The Global Ablation Technologies Market is segmented on the basis of Type, Application and Region. Based on the Type, the Global Ablation Technologies Market is sub-segmented into Radiofrequency Ablation, Laser/Light Ablation, Cryoablation Ablation, Microwave Ablation, Hydrothermal Ablation and others. On the basis of Application, the Global Ablation Technologies Market is classified into Cardiovascular Disease, Cancer, Ophthalmology, Pain Management, Gynecology and others.

Top Medical Industry News:

Johnson & Johnson (March 19, 2021) - Janssen Announces U.S. FDA Approval of PONVORY (ponesimod), an Oral Treatment for Adults with Relapsing Multiple Sclerosis Proven Superior to Aubagio (teriflunomide) in Reducing Annual Relapses and Brain Lesions - The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) approved PONVORY (ponesimod), a once-daily oral selective sphingosine-1-phosphate receptor 1 (S1P1) modulator, to treat adults with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease. PONVORY offers MS patients superior efficacy in reducing annualized relapse rates compared to an established oral therapy and a proven safety profile backed by over a decade of cumulative clinical research.

The FDA approval is based, in part, on a two-year, head-to-head Phase 3 clinical trial in which PONVORY 20 mg demonstrated superior efficacy in significantly reducing annual relapses by 30.5% compared to teriflunomide (Aubagio) 14 mg in patients with relapsing MS. Over the study period, 71% of patients treated with PONVORY had no confirmed relapses, compared to 61% in the teriflunomide group. PONVORY was also superior to teriflunomide in reducing the number of new gadolinium-enhancing (GdE) T1 lesions and the number of new or enlarging T2 lesions by 59% and 56%, respectively. GdE T1 lesions and T2 lesions are identified using magnetic resonance imaging (MRI) technology and are recognized as classic measures of MS pathology that can provide insights into disease activity and disease burden, respectively.

PONVORY also prevented disability from worsening for most people. Nine in 10 PONVORY-treated patients did not have worsening of 3-month disability, and PONVORY showed a numerical benefit in delaying disability progression. The difference in rates of disability progression was not statistically significant between the PONVORY and teriflunomide groups.

“MS is a complex disease, and any individual’s response to MS disease-modifying therapy can vary,” said Dr. Bruce Bebo, Executive Vice President of Research at the National MS Society. “It’s so important that people living with MS have access to effective treatment options. We are pleased that there is a new therapy approved for relapsing MS.”

If treatment needs to be stopped, PONVORY leaves the blood within one week, with effects on the immune system wearing off in one to two weeks for most patients. This may offer additional flexibility in treatment management if patients need to receive vaccines, address potential infections, or begin family planning. PONVORY has no known food restrictions and requires no genetic testing or first-dose monitoring for most patients.

Purchase this report online with 90 Pages, List of Tables & Figures and in-depth Table of Contents on “Global Ablation Technologies Market Report 2021” @ https://www.businessindustryreports.com/buy-now/284208/single .

Top Leading Key in Players Global Ablation Technologies Market: Medtronic, AtriCure, Dornier MedTech, Boston Scientific, AngioDynamics, Lumenis, Abbott, Smith & Nephew, Olympus, Johnson & Johnson, EDAP TMS, BTG, Hologic, IRIDEX, CONMED, Merit Medical and others. New product launches and continuous technological innovations are the key strategies adopted by the major players.

With the presence of a large pool of participants, the Global Ablation Technologies Market is displaying a highly competitive business landscape, finds a new research report by Business Industry Reports (BIR). Medtronic, AtriCure, Dornier MedTech, Boston Scientific, AngioDynamics, Lumenis, Abbott, Smith & Nephew, Olympus, Johnson & Johnson, EDAP TMS, BTG, Hologic, IRIDEX, CONMED, Merit Medical are some of the key vendors of Ablation Technologies across the world. These players across Ablation Technologies Market are focusing aggressively on innovation, as well as on including advanced technologies in their existing products.

Region segment: Ablation Technologies Market report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Ablation Technologies in these regions, from 2013 to 2025 (forecast), covering: North America, Europe, Asia Pacific, Middle East & Africa and South America

Grab Your Report at an Impressive Discount @ https://www.businessindustryreports.com/check-discount/284208 .

Major Points in Table of Contents:

Global Ablation Technologies Market Report 2021

1 Ablation Technologies Product Definition

2 Global Ablation Technologies Market Manufacturer Share and Market Overview

2.1 Global Manufacturer Ablation Technologies Shipments

2.2 Global Manufacturer Ablation Technologies Business Revenue

2.3 Global Ablation Technologies Market Overview

2.4 COVID-19 Impact on Ablation Technologies Industry

3 Manufacturer Ablation Technologies Business Introduction

3.1 Medtronic Ablation Technologies Business Introduction

3.2 AtriCure Ablation Technologies Business Introduction

3.3 Dornier MedTech Ablation Technologies Business Introduction

3.4 Boston Scientific Ablation Technologies Business Introduction

3.5 AngioDynamics Ablation Technologies Business Introduction

3.6 Lumenis Ablation Technologies Business Introduction

………………. Request free sample to get a complete Table of Content

About us

BusinessindustryReports.com is a digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that hold the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic, and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune – India

sales@businessindustryreports.com

+19376349940

This release was published on openPR.